Physician profile
Nathan A Mann
NPI 1811155112
$909.76
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.13 · 2020: $25.50 · 2022: $302 · 2023: $506 · 2024: $13.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $250.23 | 2022-2024 | |
| Novo Nordisk INC | $130.56 | 2020-2023 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $82.96 | 2022-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.01 | 2019-2022 | |
| Glaxosmithkline, LLC. | $53.75 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.38 | 2023 | |
| Astellas Pharma US INC | $32.58 | 2023 | Myrbetriq, Veozah |
| Kowa Pharmaceuticals America, INC. | $31.56 | 2022-2023 | Livalo, Seglentis |
| Lilly USA, LLC | $28.15 | 2022-2023 | Emgality, Jardiance |
| Otsuka America Pharmaceutical, INC. | $21.87 | 2023 | Rexulti |
| Hologic Sales and Service, LLC | $21.26 | 2023 | Thinprep 2000 Processor, Aptima |
| Exact Sciences Corporation | $20.64 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $18.82 | 2022 | |
| Lundbeck LLC | $17.84 | 2023 | Brintellix |
| Pfizer INC. | $16.65 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.24 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.22 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.08 | 2022 | |
| Amgen INC. | $15.01 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.